<?xml version="1.0" encoding="UTF-8"?>
<ref id="B137-viruses-12-01039">
 <label>137.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sciascia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Apr√†</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Baffa</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Baldovino</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Roccatello</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19</article-title>
  <source>Clin. Exp. Rheumatol.</source>
  <year>2020</year>
  <volume>38</volume>
  <fpage>529</fpage>
  <lpage>532</lpage>
  <pub-id pub-id-type="pmid">32359035</pub-id>
 </element-citation>
</ref>
